RESUMEN
OBJECTIVE: The aim of this study was to evaluate multiple interrelations between several endogenous and exogenous effects and the thyroid volume and function in large groups of children, adolescents, and adults with a sufficient whole life intake of the iodine. SUBJECTS AND METHODS: The data were obtained either by cross sectioned or longitudinal studies in a total of 4998 children and adolescents (aged 7 to 17 years) and 2501 adults (1071 males and 1430 females aged 20-75 years). Thyroid volume (ThV) was measured by ultrasound, antibodies, and hormones by electrochemiluminiscent immunoassay, and endocrine disruptors (EDs, polychlorinated biphenyls-PCB, dichlorodiethyl-ichloroethylene-DDE, and hexachlorobenzene-HCB) by high resolution gas chromatography/mass spectrometry. RESULTS: 1. In large groups of boys and girls of age 7, 10, 13 or 17 years, the ThV was significantly higher in the 10th decile than in pooled nine lower deciles. Moreover, in 17-year old subjects significantly higher prevalence of hypoechogenicity by ultrasound, positive thyroperoxidase antibodies (TPOab), and increased thyrotropin (TSH) levels were found in the 10th decile. 2. In a small group of children, some individuals revealed consistently higher ThV during the whole 7-year follow-up period irrespective of supplementation with iodine. 3. In 325 sibling pairs of age 10-19 years, born within three years, three groups with different ThV/m2 of body surface were distinguished: Group A (183 pairs having both ThVs small), Group B (103 pairs having both ThVs large); Group C (33 pairs having one ThV small and the other one large). Similar aggregation of ThVs in three groups was observed in 13 pairs of discordant twins and 19 sibling triads in which all the siblings were born within four years. 4. In 42 concordant twins, several pairs had ThV nearly twice as high (in terms of both plain ThV or ThV/m2 of the body surface) as several other pairs of the same age which is assumed to be a result of a genetic background. 5. In large cohorts of males and females, a highly significant positive correlation was found between the ThV and high level of TPOab on one side and EDs on the other side. However, in nearly the same numbers of subjects with low TPOab, negative correlation was seen between ThV and disruptors. These observations may apparently support the synergic effect of the autoimmunity and EDs on the thyroid function. CONCLUSIONS: Several cases of an excessive thyroid growth in the iodine replenished children, adolescents, and adults may apparently result from the autoimmune thyroiditis, probably induced by immunogenic action of iodine in presumably disposed individuals. However, in some cases even simultaneous participation of EDs can not be excluded. Some observations have also suggested that excessive thyroid growth in the iodine replenished adolescent and adult population which was equally exposed to disruptors may also result from other reasons as the unfavorable hereditary background.
Asunto(s)
Enfermedades Autoinmunes/epidemiología , Disruptores Endocrinos/efectos adversos , Enfermedades Genéticas Congénitas/epidemiología , Yodo/administración & dosificación , Enfermedades de la Tiroides/epidemiología , Glándula Tiroides/anatomía & histología , Adolescente , Adulto , Anciano , Enfermedades Autoinmunes/inducido químicamente , Enfermedades Autoinmunes/etiología , Enfermedades Autoinmunes/patología , Niño , Enfermedades Carenciales/epidemiología , Enfermedades Carenciales/etiología , Enfermedades Carenciales/patología , Ingestión de Alimentos/fisiología , Femenino , Enfermedades Genéticas Congénitas/complicaciones , Enfermedades Genéticas Congénitas/patología , Humanos , Yodo/deficiencia , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Tamaño de los Órganos/fisiología , Factores de Riesgo , Eslovaquia/epidemiología , Enfermedades de la Tiroides/inducido químicamente , Enfermedades de la Tiroides/etiología , Enfermedades de la Tiroides/patología , Glándula Tiroides/diagnóstico por imagen , Glándula Tiroides/patología , Factores de Tiempo , Ultrasonografía , Adulto JovenRESUMEN
OBJECTIVE: To evaluate whether small iodine supplements decrease the incidence of adolescent thyroid hypertrophy in an iodine-sufficient population or whether such thyroid enlargement should be considered an inevitable physiological phenomenon. DESIGN: Beginning in September 1991 (after an initial examination in September 1990), 54 11-year-old children in Bardejov, Slovakia were given small iodine supplements (Thyrojod depot tablets containing 1530 microg iodide) every 2 weeks for 2 years followed by once weekly for 2 years. A second group of 63 children served as controls. In June 1995, there were still 52 treated and 60 control children in the study and these were examined; 44 treated and 48 control children remained in the study until June 1997. METHODS: In 1990, 1993, 1995, 1996 and 1997 the thyroid volume (ThV) was measured by ultrasound. Serum levels of TSH, thyroglobulin, total and free thyroxine and tri-iodothyronine and anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-TG) and anti-TSH receptor (TSR) antibodies were estimated in 1990 and 1994, while only TSH, and anti-TPO and anti-TSR antibodies were measured in 1997. RESULTS: There was no difference between the groups at any interval in the serum levels of the hormones measured. Marginally increased TSH was found in two treated and two control children. Anti-TSR antibodies were negative in all children, while anti-TPO and anti-TG antibodies were found in one treated and four control children. At the age of 10 years (1990), 84% of all ThVs were less than 4 ml, indicating a previous life-long sufficient iodine intake. After the treatment was completed (June 1995), a significant difference in ThV (P < 0.04) was found between the whole treated (5.78 +/- 0.19 ml) and the whole control group (6.56 +/- 0.30 ml). However, there was already a marked difference in the 75th percentile (6.4 ml in treated vs 8.5 ml in controls) due to more rapid thyroid growth in certain children of the control group (ThV > 7.0 ml in 6/52 treated children vs 24/60 controls; P < 0.01). Since such differences were much higher in 1997, the children in each group whose ThV was in the range of the upper 25% in 1997 were retrospectively evaluated as arbitrary separate subgroups in all the time intervals and compared with the remaining 75% of children who showed moderate thyroid growth rate. Two years after the termination of treatment (June 1997), excessive thyroid growth continued in the upper quarter of 12 controls with the highest ThV (13.60 +/- 0.40 ml or 7.60 +/- 0.29 ml/m2; 12/12 with ThV > 11.0 ml), and a similar subgroup now also appeared in 11 previously treated children (10.79 +/- 0.51 ml or 6.19 +/- 0.30 ml/m2; 5/11 with ThV > 11.0 ml). At the same time, ThV in the remaining 75% of both control (8.12 +/- 0.38 ml or 4.82 +/- 0.17 ml/m2; 3/36 with ThV > 11.0 ml) and treated (7.20 +/- 0.30 ml or 4.39 +/- 0.17 ml/m2; 0/33 with ThV > 11.0 ml) children was significantly less (P < 0.01 to P < 0.001) than that in the appropriate rapidly growing subgroups. During the whole observation period (1990-1997), no difference was found between treated and control subgroups with moderate thyroid growth. CONCLUSIONS: Since iodine intake in Slovakia has been adequate for decades and sporadic iodine deficiency is highly unlikely, the observed excessive thyroid growth in certain adolescents may result from causes other than simple iodine deficiency (e.g. hereditary), which are nevertheless ameliorated by small iodine supplements. The question remains whether such a subgroup with rapidly growing thyroids should be included in the range of normal thyroid volumes in adolescents.
Asunto(s)
Suplementos Dietéticos , Yodo/uso terapéutico , Glándula Tiroides/patología , Adolescente , Análisis de Varianza , Autoanticuerpos/sangre , Femenino , Estudios de Seguimiento , Humanos , Hipertrofia , Yodo/orina , Masculino , Glándula Tiroides/inmunología , Glándula Tiroides/metabolismo , Hormonas Tiroideas/metabolismoRESUMEN
The thyroid volume (by ultrasonographic volumetry) was estimated in 4,254 schoolchildren and adolescents 6-18 years of age from 12 districts of Slovakia and urinary iodine (by dry alkaline ashing followed by spectrophotometry) in 1,174 spot urine samples. No differences in thyroid volume or in iodine excretion between individual districts were found. Similarly, no differences in thyroid volume between sexes were found up to the age of 14 years, however, thereafter, such volumes were considerably higher in boys. When comparing our cummulated data with those reported by others for a population with optimal iodine intake, it was found: 1. the medians for most of the examined age groups were slightly higher, 2. the percentage of values which were higher than 97 percentiles of normal population was 3.01 for the age of 6-14 years, while that for the age of 15-18 years was 9.04. Only 35.9% of all values of urinary iodine were in the optimal range (i.e. 10-20 mud/dl), while 56.1 were less than 10 micrograms/dl and 15.9% less than 5 micrograms/dl, the remaining 8.0% over 20 micrograms/dl. In spite of long-term iodine prophylaxis (since 1949), the intake of iodine apparently is still not satisfactory, since a considerable amount of individuals appeared to be iodine deficient on the day of examination. Iodine intake, however, may be marginally sufficient up to the age of about 13-14 years, while later a higher number of enlarged thyroids was found which may be classified as goitre endemy grade I.